Work

Proof-of-Concept Trial with the Neurosteroid Pregnenolone Targeting Cognitive and Negative Symptoms in Schizophrenia

Year: 2009

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Neuropsychopharmacology

DOI: 10.1038/npp.2009.26

Authors: Christine E Marx, Richard S E Keefe, Robert W Buchanan, Robert M Hamer, Jason D Kilts, Daniel W Bradford, Jennifer L Strauss, Jennifer C Naylor, Victoria M Payne, Jeffrey A Lieberman, Adam J Savitz, Linda A Leimone, Lawrence Dunn, Patrizia Porcu, A Leslie Morrow, Lawrence J Shampine

Institutions: Duke University, Duke Medical Center, University of Maryland, Baltimore, University of North Carolina at Chapel Hill, Durham VA Medical Center, VA Mid-Atlantic Health Care Network, Columbia University, Cornell University, Weill Cornell Medicine

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institute on Alcohol Abuse and Alcoholism, National Institute of Mental Health, NIH Clinical Center

Awards: NEUROSTEROIDS AND ETHANOL INTERACTIONS, Neurosteroids and Schizophrenia

OpenAlex ID: W2032359153

FWCI: 10.08

Cites: 153

Cited by: 193

Related to: 10